Barkovskiy, M.;Ilyukhina, E.;Dauner, M.;Eichinger, A.;Skerra, A.
An engineered lipocalin that tightly complexes the plant poison colchicine for use as antidote and in bioanalytical applications
Biol Chem
2019
400
3
351-366

Deuschle, F. C.;Schiefner, A.;Skerra, A.
Structural differences between the ectodomains of murine and human CD98hc
Proteins
2019
87
8
693-698

Eggenstein, E.;Richter, A.;Skerra, A.
FluoroCalins: engineered lipocalins with novel binding functions fused to a fluorescent protein for applications in biomolecular imaging and detection
Protein Eng Des Sel
2019
32
6
289-296

Fischer, J. C.;Lin, C. C.;Heidegger, S.;Wintges, A.;Schlapschy, M.;Beudert, M.;Combs, S. E.;Bassermann, F.;Skerra, A.;Haas, T.;Poeck, H.
Regeneration after radiation- and immune-mediated tissue injury is not enhanced by type III interferon signaling
Int J Radiat Oncol Biol Phys
2019
103
4
970-976

Gebauer, M.;Skerra, A.
Engineering of binding functions into proteins
Curr Opin Biotechnol
2019
60
230-241

Griffiths, K.;Binder, U.;McDowell, W.;Tommasi, R.;Frigerio, M.;Darby, W. G.;Hosking, C. G.;Renaud, L.;Machacek, M.;Lloyd, P.;Skerra, A.;Foley, M.
Half-life extension and non-human primate pharmacokinetic safety studies of i-body AD-114 targeting human CXCR4
MAbs
2019
11
7
1331-1340

Harder, M. J.;Hochsmann, B.;Dopler, A.;Anliker, M.;Weinstock, C.;Skerra, A.;Simmet, T.;Schrezenmeier, H.;Schmidt, C. Q.
Different levels of incomplete terminal pathway inhibition by eculizumab and the clinical response of PNH patients
Front Immunol
2019
10
1639

Xia, Y.;Schlapschy, M.;Morath, V.;Roeder, N.;Vogt, E. I.;Stadler, D.;Cheng, X.;Dittmer, U.;Sutter, K.;Heikenwalder, M.;Skerra, A.;Protzer, U.
PASylated interferon α efficiently suppresses hepatitis B virus and induces anti-HBs seroconversion in HBV-transgenic mice
Antiviral Res
2019
161
134-143

Weiß, Simon Christoph
Strukturelle Charakterisierung von katalytischen und regulatorischen Proteinen des Escherichia coli Maltose/Maltodextrin-Systems
2019
Dissertation
202 p.